The Indian CEO driving change

In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with Ankit Gupta, CEO at Tenshi Kaizen.

Your host, Raman Sehgal, discusses the pharmaceutical and biotechnology supply chain with Ankit, covering:

• His accidental journey into pharma, and then pharma manufacturing
• How his exposure to the pharma value chain via consulting led to numerous roles in the sector, including a critical one at Strides Pharma Sciences Limited and other group companies held by the founders
• The honour of being appointed CEO at Tenshi, and building out InstaPill(R) - its proprietary oral drug delivery technology - from incubation to growth
• Why India is poised for growth now that it's leading the 'D' as well as the 'M' of CDMO
• The lay of the land in India's biopharma and pharma ecosystem

Ankit Gupta is a seasoned finance and strategy leader with close to 15 years of experience in the pharmaceutical and biotechnology sectors. At Tenshi Kaizen, he leads the development and global expansion of innovative pharmaceutical technology platforms, including the flagship InstaPill. He also serves as the Chief Corporate Strategy & Development Officer across all group entities promoted by the founders.

Ankit is known for his expertise in corporate strategy, growth acceleration, and business transformation. In his prior role as Vice President – Strategy and Corporate Development at Gland Pharma Limited and Strides Group, he played a pivotal role in long-range planning, financial forecasting, and strategic initiatives that contributed to the Strides Group turnaround in the financial year 2022-2023.

He brings deep experience in both organic and inorganic growth, asset optimization, and risk management. A gold medalist in MBA (Finance), Ankit also holds global certifications in corporate finance, private equity, valuations, business leadership, and strategy, bringing a rare blend of financial precision and strategic foresight to the group’s leadership.

Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. 

We’d also appreciate a positive rating! 

Molecule to Market is also sponsored and funded by ramarketing, an international marketing, design, digital and content agency helping companies differentiate, get noticed and grow in life sciences.